Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134


Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas.

Myers R, Harvey M, Kaufmann TJ, Greiner SM, Krempski JW, Raffel C, Shelton SE, Soeffker D, Zollman P, Federspiel MJ, Blanco M, Galanis E.

Hum Gene Ther. 2008 Jul;19(7):690-8. doi: 10.1089/hum.2008.035.


Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.

Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC.

Cancer Res. 2003 May 15;63(10):2462-9.


Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ.

Cancer Res. 2010 Feb 1;70(3):875-82. doi: 10.1158/0008-5472.CAN-09-2762. Epub 2010 Jan 26.


Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.

Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E.

Clin Cancer Res. 2007 Dec 1;13(23):7155-65.


A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer.

McDonald CJ, Erlichman C, Ingle JN, Rosales GA, Allen C, Greiner SM, Harvey ME, Zollman PJ, Russell SJ, Galanis E.

Breast Cancer Res Treat. 2006 Sep;99(2):177-84. Epub 2006 Apr 27.


Engineered measles virus as a novel oncolytic therapy against prostate cancer.

Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E.

Prostate. 2009 Jan 1;69(1):82-91. doi: 10.1002/pros.20857.


Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.

Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW.

Clin Cancer Res. 2006 Mar 15;12(6):1868-75.


Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.

Zhang SC, Wang WL, Cai WS, Jiang KL, Yuan ZW.

BMC Cancer. 2012 Sep 25;12:427. doi: 10.1186/1471-2407-12-427.


Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.

Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J, Schroeder M, Puri RK, Russell SJ, Galanis E.

Mol Ther. 2008 Sep;16(9):1556-64. doi: 10.1038/mt.2008.152. Epub 2008 Jul 29.


Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.

Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ, Russell SJ, LaRusso NF.

Hepatology. 2006 Dec;44(6):1465-77.


Oncolytic measles virus strains in the treatment of gliomas.

Allen C, Paraskevakou G, Liu C, Iankov ID, Msaouel P, Zollman P, Myers R, Peng KW, Russell SJ, Galanis E.

Expert Opin Biol Ther. 2008 Feb;8(2):213-20. doi: 10.1517/14712598.8.2.213 . Review. Erratum in: Expert Opin Biol Ther. 2008 Jun;8(6):855. Myers, Rae [added]; Peng, Kah Whye [added]; Russell, Stephen J [added].


Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.

Paraskevakou G, Allen C, Nakamura T, Zollman P, James CD, Peng KW, Schroeder M, Russell SJ, Galanis E.

Mol Ther. 2007 Apr;15(4):677-86. Epub 2007 Feb 13.


Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.

Grossardt C, Engeland CE, Bossow S, Halama N, Zaoui K, Leber MF, Springfeld C, Jaeger D, von Kalle C, Ungerechts G.

Hum Gene Ther. 2013 Jul;24(7):644-54. doi: 10.1089/hum.2012.205.


Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates.

Jenks N, Myers R, Greiner SM, Thompson J, Mader EK, Greenslade A, Griesmann GE, Federspiel MJ, Rakela J, Borad MJ, Vile RG, Barber GN, Meier TR, Blanco MC, Carlson SK, Russell SJ, Peng KW.

Hum Gene Ther. 2010 Apr;21(4):451-62. doi: 10.1089/hum.2009.111.


Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.

Wei J, Wahl J, Nakamura T, Stiller D, Mertens T, Debatin KM, Beltinger C.

Gene Ther. 2007 Nov;14(22):1573-86. Epub 2007 Sep 27.


Heat shock protein inhibitors increase the efficacy of measles virotherapy.

Liu C, Erlichman C, McDonald CJ, Ingle JN, Zollman P, Iankov I, Russell SJ, Galanis E.

Gene Ther. 2008 Jul;15(14):1024-34. doi: 10.1038/gt.2008.30. Epub 2008 Mar 20.


MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.

Leber MF, Bossow S, Leonard VH, Zaoui K, Grossardt C, Frenzke M, Miest T, Sawall S, Cattaneo R, von Kalle C, Ungerechts G.

Mol Ther. 2011 Jun;19(6):1097-106. doi: 10.1038/mt.2011.55. Epub 2011 Apr 5.


Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

Opyrchal M, Allen C, Iankov I, Aderca I, Schroeder M, Sarkaria J, Galanis E.

Hum Gene Ther. 2012 Apr;23(4):419-27. doi: 10.1089/hum.2011.158. Epub 2012 Mar 9.


The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain.

Duprex WP, Duffy I, McQuaid S, Hamill L, Cosby SL, Billeter MA, Schneider-Schaulies J, ter Meulen V, Rima BK.

J Virol. 1999 Aug;73(8):6916-22.


Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.

Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E.

Mol Ther. 2009 Dec;17(12):2041-8. doi: 10.1038/mt.2009.218. Epub 2009 Sep 22.

Supplemental Content

Support Center